Here are the top health stories of the day: Attacks on doctors threaten Lives and patient safety in Hospitals: Delhi HC Warns While considering a criminal case against a patient’s attendant who had allegedly assaulted a doctor, the Delhi High Court bench took note of the compromise entered into between the parties and held that […]
New Delhi: The Subject Expert Committee (SEC) on Oncology under the Central Drugs Standard Control Organization (CDSCO) has raised critical concerns over the Phase III clinical trial proposal of Sacituzumab Tirumotecan submitted by MSD Pharmaceuticals Pvt. Ltd., directing the company to provide detailed justifications regarding its study design and patient representation in India. MSD Pharmaceuticals […]
Jaipur: The cough syrup controversy in Rajasthan has now led to suspensions and sweeping new guidelines, as the health department cracked down on lapses following the deaths of children allegedly linked to dextromethorphan hydrobromide syrup. The state government suspended a pharmacist and a doctor of Hathideh PHC in Ajitgarh block, Sikar, for allegedly prescribing the […]
Thane: An orthopaedic surgeon from Ambernath has been accused of sexual exploitation by a woman. The woman, whose husband was earlier treated by the doctor, alleged that he took advantage of her following her husband’s death. Alleging the doctor sexually assaulted her under the pretext of marriage, the widow filed a complaint against the doctor, […]
New Delhi: The Department of Pharmaceuticals (DoP) has notified major amendments to the Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) through a recent Gazette notification, with a massive financial outlay of Rs 5000 crore from FY 2023-24 to FY 2029-30. The scheme aims to transform India’s pharma and MedTech sector […]
Italy: A new review published in Minerva Medica has revealed that GLP-1 receptor agonists may help preserve kidney function in people with type 2 diabetes. Researchers led by Alessandro Perencin from the Department of Medicine (DIMED), Geriatrics Division, University of Padua, Italy, conducted a systematic review to examine whether this class of diabetes medications could […]
USA: Researchers have found in a retrospective study that GLP-1 receptor agonists (RAs) are generally safe for the gastrointestinal (GI) and hepatobiliary systems in patients with type 2 diabetes (T2D). The study published in the American Journal of Gastroenterology revealed that the therapy was linked to lower risks of several GI cancers and complications compared with […]
Continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before non-cardiac surgery is linked to a reduced risk of postoperative mortality and functional decline, according to researchers from Science Tokyo. Using a Japanese nationwide registry of 2.6 million patients over 50 years old, the researchers compared outcomes between those who continued antihypertensive therapy and those […]
A randomized controlled trial published in the Journal of Indian Society of Pedodontics and Preventive Dentistry (July–September 2025 issue) by Shrikant Bhujangrao Kendre, Anuja U. Bhatane, Mahesh Vilasrao Dadpe, Yogesh Jagannath Kale, and Prasanna Trambakrao Dahake has reported that sequential herbal irrigation may offer a safe and effective alternative to conventional irrigants in the endodontic […]
Belgium: Patients living with sarcoidosis appear to be at a markedly higher risk of developing psychiatric symptoms compared to healthy adults, a new systematic review and meta-analysis published in Frontiers in Medicine has revealed. The study by Andreas Frans and colleagues from the Department of Medical Psychology and Psychiatry, Antwerp University Hospital, Belgium, highlights the […]